A review of the therapeutic management of ulcerative colitis-Reference-Cited by-同舟云学术

A review of the therapeutic management of ulcerative colitis

Published:2022-01 Issue: Volume:15 Page:175628482211381
ISSN:1756-2848
Container-title:Therapeutic Advances in Gastroenterology
language:en
Short-container-title:Therap Adv Gastroenterol

Author:

Aslam Nasar¹,Lo Sheng Wei²,Sikafi Rafid³,Barnes Tom⁴,Segal Jonathan⁵⁶^ORCID,Smith Philip J⁷,Limdi Jimmy K⁸⁹^ORCID

Affiliation:

1. Department of Gastroenterology, University College London Hospitals, 235 Euston Road, London, NW1 2BU, UK

2. Northern Hospital, Epping, VIC, Australia

3. St Mark’s Hospital, London North West University Healthcare NHS Trust, London, UK

4. Section of IBD – Division of Gastroenterology, Northern Care Alliance NHS Foundation Trust, Salford, UK

5. Northern Hospital, Epping, Melbourne, VIC, Australia

6. Department of Medicine, University of Melbourne, Parkville, VIC, Australia

7. Department of Gastroenterology, Royal Liverpool Hospital, Liverpool University Hospitals Foundation NHS Trust, Liverpool, UK

8. Section of IBD – Division of Gastroenterology, Northern Care Alliance NHS Foundation Trust, Manchester, UK

9. Manchester Academic Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Abstract

Ulcerative colitis (UC) is a chronic relapsing and remitting gastrointestinal disorder of uncertain aetiology. The last two decades have seen an expansion in the therapeutic arsenal used to treat UC. This has resulted in improved clinical remission and response rates. Nonetheless, staples in our current medical management originate from trials conducted in the early 20th century. In this review article, we aim to outline the key milestones in the history of the medical management of UC in addition to highlighting promising therapeutic developments for the future.

Publisher

SAGE Publications

Subject

Gastroenterology

Link

http://journals.sagepub.com/doi/pdf/10.1177/17562848221138160

Reference129 articles.

1. Ulcerative colitis

2. Historical evolution of the management of severe ulcerative colitis

3. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

4. Cortisone in Ulcerative Colitis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurological Side Effects of TNF-α Inhibitors Revisited: A Review of Case Reports;Medicina;2024-08-28

2. Real-World Treatment Persistence Among Advanced Therapy-Naïve or -Experienced Patients with Ulcerative Colitis Initiated on Ustekinumab or Adalimumab;Advances in Therapy;2024-08-14

3. Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study;Inflammatory Bowel Diseases;2024-08-10

4. Natural approaches for the management of ulcerative colitis: evidence of preclinical and clinical investigations;Natural Products and Bioprospecting;2024-07-30

5. Treatment of active ulcerative colitis with Yinmei Kuijie decoction combined with 5-aminosalicylic acid: A non-randomized multicenter prospective observational protocol based on real-world conditions;Journal of Traditional Chinese Medical Sciences;2024-07